RGEN · Repligen Corp
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-16 | Garland Jason K |
EVP, Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025. |
Common Stock
|
530 |
| 2026-06-25 | Garland Jason K |
EVP, Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025. |
Common Stock
|
733 |
| 2026-05-14 | Pax Margaret |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Ms. Pax was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
995 |
| 2026-05-14 | DAWES KAREN A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Ms. Dawes was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
995 |
| 2026-05-14 | DAWES KAREN A |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. |
Stock Option (Right to Buy)
|
2,239 |
| 2026-05-14 | Mhatre Rohin |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Mhatre was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
995 |
| 2026-05-14 | Konstantinov Konstantin |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Konstantinov was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
995 |
| 2026-05-14 | BARTHELEMY NICOLAS |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Barthelemy was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The Reporting Person has elected to defer settlement of these restricted stock units pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the separation of the Reporting Person's service as a Director. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
995 |
| 2026-05-14 | Mhatre Rohin |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. |
Stock Option (Right to Buy)
|
2,239 |
| 2026-05-14 | EGLINTON MANNER CARRIE |
Director, President & CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Ms. Manner was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
995 |
| 2026-05-14 | EGLINTON MANNER CARRIE |
Director, President & CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. |
Stock Option (Right to Buy)
|
2,239 |
| 2026-05-14 | MUIR GLENN P |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. |
Stock Option (Right to Buy)
|
2,239 |
| 2026-05-14 | Madaus Martin D |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Madaus was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The Reporting Person has elected to defer settlement of these restricted stock units pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the separation of the Reporting Person's service as a Director. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
995 |
| 2026-05-14 | Pax Margaret |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. |
Stock Option (Right to Buy)
|
2,239 |
| 2026-05-14 | BARTHELEMY NICOLAS |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. |
Stock Option (Right to Buy)
|
2,239 |
| 2026-05-14 | Konstantinov Konstantin |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. |
Stock Option (Right to Buy)
|
2,239 |
| 2026-05-14 | Madaus Martin D |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. |
Stock Option (Right to Buy)
|
2,239 |
| 2026-05-14 | MUIR GLENN P |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Muir was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The Reporting Person has elected to defer settlement of these restricted stock units pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the separation of the Reporting Person's service as a Director. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
995 |
| 2026-05-07 | MUIR GLENN P |
Director |
Convert↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option is fully vested and exercisable. |
Stock Option (Right to Buy)
|
2,434 |
| 2026-05-07 | Douglass Brian Robb |
CHIEF PRODUCT OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
334 |
| 2026-05-07 | MUIR GLENN P |
Director |
Convert↑
|
Common Stock
|
2,434 |
| 2026-04-21 | Loeillot Olivier |
Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on August 19th, 2025. |
Common Stock
|
3,832 |
| 2026-03-05 | KURIYEL RALF |
Senior VP, R&D |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029. |
Stock Option (Right to Buy)
|
5,669 |
| 2026-03-05 | Loeillot Olivier |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029. |
Stock Option (Right to Buy)
|
25,890 |
| 2026-03-05 | Garland Jason K |
EVP, Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Garland was awarded 7,751 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
7,751 |
| 2026-03-05 | Bylund James |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Bylund was awarded 7,751 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
7,751 |
| 2026-03-05 | Loeillot Olivier |
Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Loeillot was awarded 24,134 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
24,134 |
| 2026-03-05 | Garland Jason K |
EVP, Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029. |
Stock Option (Right to Buy)
|
8,315 |
| 2026-03-05 | KURIYEL RALF |
Senior VP, R&D |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Kuriyel was awarded 5,284 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
Common Stock
|
5,284 |
| 2026-03-05 | Bylund James |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029. |
Stock Option (Right to Buy)
|
8,315 |
| 2026-03-04 | Bylund James |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 125 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2025. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. |
Common Stock
|
125 |
| 2026-03-04 | KURIYEL RALF |
Senior VP, R&D |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 125 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2025. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. |
Common Stock
|
125 |
| 2026-03-04 | Bylund James |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of the performance stock units. |
Common Stock
|
62 |
| 2026-03-04 | KURIYEL RALF |
Senior VP, R&D |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of the performance stock units. |
Common Stock
|
42 |
| 2026-03-02 | Loeillot Olivier |
Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
1,610 |
| 2026-03-02 | Hunt Anthony |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
9,897 |
| 2026-03-02 | KURIYEL RALF |
Senior VP, R&D |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
923 |
| 2026-03-02 | Garland Jason K |
EVP, Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
715 |
| 2026-03-02 | Bylund James |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
2,433 |
| 2026-03-02 | Douglass Brian Robb |
CHIEF PRODUCT OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
221 |
| 2026-02-27 | Loeillot Olivier |
Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
344 |
| 2026-02-27 | Garland Jason K |
EVP, Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
327 |
| 2026-02-27 | KURIYEL RALF |
Senior VP, R&D |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
444 |
| 2026-02-27 | Bylund James |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Common Stock
|
1,478 |
| 2025-12-31 | Douglass Brian Robb |
CHIEF PRODUCT OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in substantially equal installments over a three-year period with each such vesting date occurring on the anniversary of the grant date. |
Stock Option (Right to Buy)
|
2,143 |
| 2025-12-31 | Douglass Brian Robb |
CHIEF PRODUCT OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Douglass was awarded 2,288 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in substantially equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock. |
Common Stock
|
2,288 |
| 2025-12-17 | DAWES KAREN A |
Director |
Sell↓
|
Common Stock
|
275 |
| 2025-12-16 | MUIR GLENN P |
Director |
Convert↑
|
Common Stock
|
3,366 |
| 2025-12-16 | MUIR GLENN P |
Director |
Convert↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option is fully vested and exercisable. |
Stock Option (Right to Buy)
|
3,366 |
| 2025-12-04 | Hunt Anthony |
Director |
Other↓
Filing footnotes — Common Stock (Direct)
Represents a transfer of shares for which the Reporting Person is a joint tenant with right of survivorship. |
Common Stock
|
2,000 |